Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events

Camrelizumab-Induced Isolate Abducens Neuritis: A Rare Ophthalmic Immune-Related Adverse Events

Background: Anti-tumor immunotherapy with immune checkpoint inhibitors induces several immune-related adverse events. Camrelizumab-related isolate abducens neuritis is rare. Case presentation: We report on a 67-year-old man with esophageal cancer who presented with acute-onset isolated right abducen...

Full description

Bibliographic Details
Main Authors:	Yanli Hou, Qiang Su, Simeng Tang, Hongyang Li
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	Brain Sciences
Subjects:	immunotherapy abducens neuritis Camrelizumab immune-related adverse events case report
Online Access:	https://www.mdpi.com/2076-3425/12/9/1242

Similar Items

Case report: A rare immune-related adverse effect: hepatic cavernous hemangioma induced by camrelizumab
by: Chuantao Zhang, et al.
Published: (2024-04-01)

Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder Carcinoma
by: Yonghao Yang, et al.
Published: (2021-10-01)

Efficacy and safety of camrelizumab plus transarterial chemoembolization in intermediate to advanced hepatocellular carcinoma patients: A prospective, multi-center, real-world study
by: Ran You, et al.
Published: (2022-08-01)

Bilateral optic neuritis attributed to Pembrolizumab: A case report
by: Dr Lucy G Faulkner, et al.
Published: (2024-03-01)

Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgery
by: Xudan Wang, et al.
Published: (2023-12-01)

A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma
by: Houyu Ju, et al.
Published: (2023-08-01)

Paralytic squint due to abducens nerve palsy : a rare consequence of dengue fever
by: Shivanthan Mitrakrishnan C, et al.
Published: (2012-07-01)

Case report: A case of acute mastitis associated with reactive cutaneous capillary endothelial proliferation after camrelizumab treatment: A new immune-related adverse event
by: Ping-Shang Wu, et al.
Published: (2022-08-01)

Efficacy of Combination of Camrelizumab with Anlotinib as Third-line Therapy for Patients with Advanced Non-small Cell Lung Cancer
by: ZHANG Xiaojuan, et al.
Published: (2023-06-01)

Recurrent pleural effusion as a rare manifestation after prolonged PD1 inhibitor (camrelizumab)-based immunotherapy: A case report
by: Xiao-Hong Xie, et al.
Published: (2023-08-01)

Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I study
by: Li Zhou, et al.
Published: (2022-05-01)

Paralysie du nerf abducens droit révélant une pansinusite
by: Adil Bouzidi, et al.
Published: (2015-06-01)

Early division of the abducens nerve's prefissural segment: Report of the rarely described variant
by: Robert Haładaj, et al.
Published: (2023-11-01)

A rare case of post traumatic isolated bilateral abducens nerve palsy
by: Manish Jaiswal, et al.
Published: (2014-12-01)

A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas
by: Yan Zhou, et al.
Published: (2023-11-01)

Apatinib combined with camrelizumab in the treatment of recurrent/metastatic nasopharyngeal carcinoma: a prospective multicenter phase II study
by: Yunyan Mo, et al.
Published: (2024-01-01)

Isolated Abducens Nerve Palsy after Lumbar Puncture – a Case Report
by: Nevena Grbić, et al.
Published: (2023-01-01)

Abducens Nerve Palsy as a Presenting Symptom of Multiple Sclerosis
by: Arun NE Sundaram, et al.
Published: (2022-08-01)

Case report: Camrelizumab associated with central retinal vein occlusion
by: Yixiang Zhan, et al.
Published: (2022-11-01)

Acute abducens nerve palsy after COVID-19 vaccination in a young adult
by: Neelam Pawar, et al.
Published: (2021-01-01)

Simultaneous involvement of optic and abducens nerves by Lyme disease: Case report with review of the literature
by: Iman Dabiri, et al.
Published: (2019-09-01)

Clinical analysis of abducens nerve palsy treated by electroacupuncture
by: Chao-Ting Ma, et al.
Published: (2015-12-01)

Abducens Palsy and Anosmia Associated with COVID-19: A Case Report
by: Jessica E. Francis
Published: (2021-01-01)

Petrositis With Bilateral Abducens Nerve Palsies complicated by Acute Otitis Media
by: Kyu Young Choi, et al.
Published: (2014-03-01)

Comparison of effectiveness and safety of camrelizumab between HBV-related and non-B, non-C hepatocellular carcinoma: A retrospective study in China
by: Haonan Liu, et al.
Published: (2022-09-01)

Treatment of Multiple Primary Malignancies With PD-1 Inhibitor Camrelizumab: A Case Report and Brief Literature Review
by: Yuchen Wan, et al.
Published: (2022-07-01)

Antitumor activity and safety of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma: An open-label, multicenter, phase II study
by: Yanfei Liu, et al.
Published: (2023-04-01)

First-line treatment of camrelizumab combined with chemotherapy in advanced gastroenteropancreatic neuroendocrine carcinoma: Study protocol for a prospective, multicenter, phase II study
by: Xiaofen Li, et al.
Published: (2022-09-01)

Isolated abducens nerve palsy after closed head injury in a child
by: Ioannis Asproudis, et al.
Published: (2015-01-01)

Adverse Events of Oncologic Immunotherapy and Their Management
by: Fedricker Diane Barber
Published: (2019-01-01)

Effects of Intraorbital Electroacupuncture on Diabetic Abducens Nerve Palsy
by: Ling-Yun Zhou, et al.
Published: (2017-01-01)

No split, no tenotomy transposition procedure for complete abducens palsy
by: Sowmya Raveendra Murthy
Published: (2017-01-01)

A retrospective pilot study of transarterial chemoembolisation using camrelizumab-eluting Callisphere beads for unresectable hepatocellular carcinoma
by: Xiaonan Shi, et al.
Published: (2023-11-01)

Emerging treatments for reactive cutaneous capillary endothelial proliferation
by: Yi Liu, et al.
Published: (2023-01-01)

Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial
by: Yanfei Liu, et al.
Published: (2024-03-01)

Delayed bilateral abducens nerve palsy after head trauma: a case report
by: Peng⁃fei YAO, et al.
Published: (2012-04-01)

A Correlation Evaluation Between the Peripheral Blood Index and the Prognosis of Advanced Esophageal Squamous Cell Carcinoma Patients Treated with Camrelizumab
by: Shang H, et al.
Published: (2024-03-01)

Idiopathic Cavernous Sinus Thrombosis Presenting Unilateral Abducens Nerve Palsy
by: Cheolsoo Han, et al.
Published: (2014-12-01)

Could Camrelizumab Plus Chemotherapy Improve Clinical Outcomes in Advanced Malignancy? A Systematic Review and Network Meta-Analysis
by: Chao Yang, et al.
Published: (2021-08-01)

Optic neuritis updates (ORP-57)
by: Nahid Beladi Moghadam
Published: (2023-01-01)